Wageningen-based FoodTech scale-up Revyve has raised nearly €24 million in Series B to accelerate the rollout of functional yeast proteins designed to replace eggs and additives in mainstream food categories – bringing total capital raised to more than €40 million.
The Series B round was co-led by ABN AMRO Sustainable Impact Fund and Invest-NL with regional support from Brabantse Ontwikkelings Maatschappij (BOM) and strategic investments by Lallemand Bio-Ingredients’ Swiss affiliate Danstar Ferment and Grey Silo Ventures (CVC of Cereal Docks Group). Existing investors Oost NL and Royal Cosun doubled down on their commitment.
“Food manufacturers are cutting back on eggs to offset increasing prices and reach sustainability targets, but replicating their unique functionality is crucial to maintaining the texture and mouthfeel consumers are used to. This is exactly where our Yeast Proteins come in, providing an affordable and clean label solution for egg replacement or egg reduction,” said Cedric Verstraeten, CEO of Revyve.
He adds: “This funding round marks a tipping point for us: allowing us to modularly scale production and branch out to more food categories and serve our sustainable solutions to larger customers worldwide.”
Founded in 2021, Revyve, is a purpose-driven FoodTech company with the goal of creating a more sustainable food system. The company arose from Wageningen University & Research (WUR) in the Netherlands, where its founding scientists discovered the potential of yeast to mimic the functionality of eggs.
Revyve’s ingredients introduce authentic textures that help replace animal proteins and “clean up” product labels.
“We are excited to partner with Revyve as they pioneer pressing sustainable alternatives to traditional egg ingredients. Their solution addresses a critical need in the food transition: scalable ingredients with a low environmental footprint and compelling economics for food manufacturers.
“We believe this combination of commercial viability and measurable sustainable benefits makes Revyve uniquely positioned to grow into a global leader. We look forward to supporting their journey,” said Hanna Zwietering, ABN AMRO SIF Senior Investment Manager.
Revyve produces highly functional yeast proteins that mimic the performance of eggs in food categories such as bakery, sauces, alternative meat and plant-based dairy. Unlike many substitutes, Revyve’s ingredients are natural, more sustainable, and price competitive, helping manufacturers respond to three pressing industry challenges:
- Rising egg costs: Volatile pricing is driving demand for affordable and price stable alternatives.
- Scrutiny of ultra-processed foods: Brands are under pressure to eliminate additives while keeping functionality.
- Sustainability: Major retailers and food manufacturers are demanding cuts to CO₂ footprints across the supply chain.
Lisette Kersting-van der Boog, Senior Investment Manager of Invest-NL adds: “With their functional egg-replacement ingredients, Revyve can play a major role in accelerating the global protein transition and fostering circular solutions that reduce pressure on land, water and animals. We are proud to invest in this Dutch company, which strengthens the country’s innovative power with a pioneering technology that has the potential to transform food production worldwide.”
In 2024, Revyve commissioned its first-of-a-kind (FOAK) production facility in Dinteloord, the Netherlands. Already running at capacity for several customers, the site has proven the company’s ability to produce and sell industrial volumes. With this new investment, Revyve will expand output to over 1,600 tons per year, ensuring reliable supply for global accounts.
Verstraeten adds: “Strong regional support from both the Wageningen and Brabant ecosystems has enabled us to scale to industrial levels in record time. With a stellar team and strong investor backing, we have an incredibly solid foundation for global expansion.”
With industrial production in full swing, Revyve is already serving customers across Europe, UK, USA, Canada, Mexico and Australia.
“Revyve’s plans align seamlessly with our mission to position Brabant as the Scale-Up Plant of Europe. Their breakthrough technology not only contributes to a more sustainable food system but also exemplifies the kind of bold innovation we aim to foster in the region. We’re proud to support Revyve in scaling their impact from Brabant to the world,” added Ingrid Nieweg, Investment Manager at BOM.
Read the orginal article: https://www.eu-startups.com/2025/09/dutch-scale-up-revyve-secures-e24-million-funding-to-boost-egg-replacing-yeast-proteins/
